Login / Signup

Update of the GIMEMA MDS0306 study: Deferasirox for lower risk transfusion-dependent patients with myelodysplastic syndromes.

Alfonso PiciocchiValeria SargentiniFrancesca CotugnoKatia BontempiGermana BeltramiAnna Angela Di TucciMarta RivaGiulia QuaresminiDaniele VallisaCarlo FinelliLorenza BorinPaola FaziMarco VignettiEmanuele Angelucci
Published in: European journal of haematology (2019)
Keyphrases
  • sickle cell disease